相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy
Xiu Gu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
HDAC6 in Diseases of Cognition and of Neurons
Patrizia LoPresti
CELLS (2021)
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
Xin-Hui Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model
Sida Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
Margherita Brindisi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019)
Xingrui He et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2020)
Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model
Elisabeth Rossaert et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
Alan P. Kozikowski et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors
Katharina Voegerl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease
Veronick Benoy et al.
BRAIN (2018)
5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes
Hsueh-Yun Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model
Sheng-Jun Fan et al.
CELL DEATH & DISEASE (2018)
Design, Synthesis, and Blood Brain Barrier Transport Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors
Seiya Hiranaka et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport
Heesun Choi et al.
MOLECULAR NEURODEGENERATION (2017)
Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury
Wencheng Jian et al.
NEUROSCIENCE LETTERS (2017)
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
Nicholas J. Porter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
Wenting Guo et al.
NATURE COMMUNICATIONS (2017)
The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity
Ahmed T. Negmeldin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Enhancement of Stress Resilience Through Histone Deacetylase 6-Mediated Regulation of Glucocorticoid Receptor Chaperone Dynamics
Jeanine Jochems et al.
BIOLOGICAL PSYCHIATRY (2015)
MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors
W. A. Gold et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance
Casey Cook et al.
HUMAN MOLECULAR GENETICS (2014)
Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
Jeanine Jochems et al.
NEUROPSYCHOPHARMACOLOGY (2014)
A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome
Xin Xu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
Nambirajan Govindarajan et al.
EMBO MOLECULAR MEDICINE (2013)
HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
Claudia Simoes-Pires et al.
MOLECULAR NEURODEGENERATION (2013)
Releasing the brake: restoring fast axonal transport in neurodegenerative disorders
Maria-Victoria Hinckelmann et al.
TRENDS IN CELL BIOLOGY (2013)
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo et al.
BLOOD (2012)
Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
Joel A. Bergman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
HDAC6 Regulates Glucocorticoid Receptor Signaling in Serotonin Pathways with Critical Impact on Stress Resilience
Julie Espallergues et al.
JOURNAL OF NEUROSCIENCE (2012)
Histone deacetylase 6 gates the synaptic action of acute stress in prefrontal cortex
Janine B. Lee et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Loss of Deacetylation Activity of Hdac6 Affects Emotional Behavior in Mice
Masahide Fukada et al.
PLOS ONE (2012)
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease
Constantin d'Ydewalle et al.
NATURE MEDICINE (2011)
HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
Joo-Yong Lee et al.
EMBO JOURNAL (2010)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Multiple roles of HDAC inhibition in neurodegenerative conditions
De-Maw Chuang et al.
TRENDS IN NEUROSCIENCES (2009)
HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation
R. B. Parmigiani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: Analysis of the National Brain Databank microarray collection
Rajiv P. Sharma et al.
SCHIZOPHRENIA RESEARCH (2008)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
The physiological and pathophysiological roles of neuronal histamine: An insight from human positron emission tomography studies
Kazuhiko Yanai et al.
PHARMACOLOGY & THERAPEUTICS (2007)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
分享论文
